ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294 | -29.5% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $417 | -12.6% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $477 | -74.5% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $1,869 | -6.6% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -66.7% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $8,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | -27.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $11,000 | -26.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $15,000 | +66.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | +63.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | -21.4% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | +8.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -45.5% | 300 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $22,000 | +10.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $20,000 | +33.3% | 300 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $15,000 | +7.1% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | +27.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | +175.0% | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | +75.0% | 300 | +100.0% | 0.00% | 0.0% |
| Q3 2015 | $4,000 | -50.0% | 150 | +50.0% | 0.00% | 0.0% |
| Q2 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |